InvestorsHub Logo

rkrw

02/23/11 11:00 PM

#115408 RE: oc631 #115407

That's a sorry way of looking at it. This is personalized medicine, showing that understanding biology is the best way to develop a drug. The data is highly impressive.

genisi

02/24/11 3:50 AM

#115428 RE: oc631 #115407

VRTX/VX-770 in CF

I'd say data are stellar for G551D mutation carriers, and there's still hope for the F508del mutation carriers that the VX-809/VX-770 combo therapy will work with acceptable safety profile.